Skip to main content
INNV
NASDAQ Industrial Applications And Services

InnovAge Posts Q4 Beat, Swings to Profit, and Issues FY27 Guidance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$11.505
Mkt Cap
$1.428B
52W Low
$3.686
52W High
$12.64
52W Position info
212% above low
Off High info
9.0% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

INNV has more than doubled off its 52-week low of $3.686.

Summary

InnovAge beat Q4 revenue estimates by 10%, swung to a quarterly profit, and guided fiscal 2027 revenue to $1.05B-$1.085B with Adjusted EBITDA of $105M-$115M.


Key Events · Earnings and Guidance · INNV

  • Q4 Revenue Beat by 10%

    Fiscal Q4 revenue of $261.95M exceeded the $238.27M consensus, driven by higher participant census of approximately 8,230 versus 7,740 a year ago.

  • Swung to Quarterly Profit

    Net income of $9.78M in Q4 versus a $5.01M loss a year earlier; Adjusted EBITDA more than doubled to $24.28M from $11.33M.

  • FY27 Guidance Issued

    Management guided fiscal 2027 revenue to $1,050M-$1,085M and Adjusted EBITDA to $105M-$115M, implying continued double-digit growth.

  • Litigation Costs Remain Elevated

    Fiscal 2026 litigation costs and settlements totaled $56.97M, including $52.4M of accrued loss for potential resolutions or paid settlements.


Analysis · INNV · Industrial Applications And Services

A strong fiscal Q4 underscores the scalability of the PACE model: revenue of $261.95M beat consensus by 10%, net income swung to $9.78M from a $5.01M loss a year ago, and Adjusted EBITDA more than doubled to $24.28M. Full-year revenue grew 15.9% to $989.7M, and the company nearly broke even with a net loss of just $0.68M versus $35.34M in fiscal 2025. Management issued fiscal 2027 guidance calling for revenue of $1.05B-$1.085B and Adjusted EBITDA of $105M-$115M, implying continued double-digit growth. Litigation costs remain a drag, however—$56.97M for the year, including $52.4M in accrued settlements.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, INNV was trading at $11.51 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $3.69 to $12.64. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

INNV - Latest Insights

INNV
Nov 03, 2026, 5:04 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $8.85
Real-time Price: $9.47 info
Change: +$0.620 (+7%) info
Market Cap: $1.292B info
INNV
Nov 03, 2026, 4:07 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $8.85
Real-time Price: $9.47 info
Change: +$0.620 (+7%) info
Market Cap: $1.292B info
INNV
Nov 03, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $8.85
Real-time Price: $9.47 info
Change: +$0.620 (+7%) info
Market Cap: $1.292B info
INNV
Sep 23, 2026, 2:46 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $9.65
Real-time Price: $9.47 info
Change: -$0.180 (-2%) info
Market Cap: $1.292B info
INNV
Sep 22, 2026, 5:19 PM EDT
Filing Type: 424B7
Importance Score:
7
Price at Filing: $9.51
Real-time Price: $9.47 info
Change: -$0.040 (-0.42%) info
Market Cap: $1.292B info